<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>91(3)</volume><submitter>Barta H</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Prognostic value of proton MR spectroscopy (H-MRS) in hypoxic-ischemic encephalopathy (HIE) is acknowledged; however, effects of gestational age (GA) and postnatal age (PA) on prediction and metabolite levels are unknown.&lt;h4>Methods&lt;/h4>One hundred and sixty-nine newborns with moderate-to-severe HIE were studied, having ≥1 H-MRS scan during postnatal days 0-14 and known neurodevelopmental outcome (Bayley-II score/cerebral palsy/death). Initial scans were categorized by PA (day 1-3/4-6/≥7), and metabolite ratios were compared by predictive value. Metabolite dynamics were assessed in a total of 214 scans performed in the study population, using regression modeling, with predictors GA, PA, and outcome.&lt;h4>Results&lt;/h4>N-acetyl-aspartate (NAA)/creatine (Cr) and myo-inositol (</pubmed_abstract><journal>Pediatric research</journal><pagination>581-589</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8904256</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Predictive performance and metabolite dynamics of proton MR spectroscopy in neonatal hypoxic-ischemic encephalopathy.</pubmed_title><pmcid>PMC8904256</pmcid><pubmed_authors>Barta H</pubmed_authors><pubmed_authors>Kovacs L</pubmed_authors><pubmed_authors>Schiever N</pubmed_authors><pubmed_authors>Jermendy A</pubmed_authors><pubmed_authors>Szabo M</pubmed_authors><pubmed_authors>Rudas G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Predictive performance and metabolite dynamics of proton MR spectroscopy in neonatal hypoxic-ischemic encephalopathy.</name><description>&lt;h4>Background&lt;/h4>Prognostic value of proton MR spectroscopy (H-MRS) in hypoxic-ischemic encephalopathy (HIE) is acknowledged; however, effects of gestational age (GA) and postnatal age (PA) on prediction and metabolite levels are unknown.&lt;h4>Methods&lt;/h4>One hundred and sixty-nine newborns with moderate-to-severe HIE were studied, having ≥1 H-MRS scan during postnatal days 0-14 and known neurodevelopmental outcome (Bayley-II score/cerebral palsy/death). Initial scans were categorized by PA (day 1-3/4-6/≥7), and metabolite ratios were compared by predictive value. Metabolite dynamics were assessed in a total of 214 scans performed in the study population, using regression modeling, with predictors GA, PA, and outcome.&lt;h4>Results&lt;/h4>N-acetyl-aspartate (NAA)/creatine (Cr) and myo-inositol (</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-03-27T16:43:25.946Z</modification><creation>2025-04-04T12:56:34.645Z</creation></dates><accession>S-EPMC8904256</accession><cross_references><pubmed>34489532</pubmed><doi>10.1038/s41390-021-01626-z</doi></cross_references></HashMap>